<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03001843</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201500836 -A</org_study_id>
    <nct_id>NCT03001843</nct_id>
  </id_info>
  <brief_title>Ketamine vs Hydromorphone</brief_title>
  <official_title>Does a Ketamine Infusion Decrease Post Operative Narcotic Consumption After Gastric Bypass Surgery?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will help to determine if investigators can minimize narcotic use in laparoscopic
      gastric bypass patients while maintaining adequate pain control. This will allow
      investigators to minimize the negative side effects of narcotics which is a goal in this
      population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a head to head observational study of patients who have undergone gastric
      bypass surgery. The methods of intraoperative anesthesiology will be Ketamine or Narcotic.
      Both are FDA approved methods of delivering anesthesia.

      The amount of narcotics a patient receives is part of the medical record post-operatively
      will be followed from post-anesthesia care unit (PACU) through to discharge. The amount of
      narcotics needed to control the patient's pain (converted to morphine equivalent units) and
      pain scores (a hospital standard measure) will be collected for 48 hours for the study, or
      until discharge, whichever occurs sooner. The conversion to a morphine equivalent unit allows
      investigators to compare different narcotics the patient may receive in a more standardized
      way. The results will be analyzed and compared between the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 22, 2017</start_date>
  <completion_date type="Actual">December 21, 2018</completion_date>
  <primary_completion_date type="Actual">December 21, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine Equivalent Daily Dose (MEDD)</measure>
    <time_frame>48 hours</time_frame>
    <description>Used to translate the dose and route of each of the opioids the patient has received over the last 48 hours to a parenteral morphine equivalent using a standard conversion table.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparative Pain Scale</measure>
    <time_frame>48 hours</time_frame>
    <description>0-10 pain scale. 0 = no pain and 10 = worst pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Laparoscopic Gastric Bypass</condition>
  <condition>Obesity</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Non-Ketamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive intraoperative narcotics as is usually done for this surgery. This arm will not receive Ketamine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive an intraoperative infusion of ketamine rather than narcotics to control pain.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Anesthesia of only Ketamine</description>
    <arm_group_label>Ketamine</arm_group_label>
    <other_name>Ketalar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Narcotics</intervention_name>
    <description>The narcotic group will receive no ketamine but rather a more standard anesthetic</description>
    <arm_group_label>Non-Ketamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>pain scale</intervention_name>
    <description>0-10 pain scale. 0 = no pain and 10 = worst pain</description>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_label>Non-Ketamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obese patient presenting for laparoscopic gastric bypass between 18 and 65 years of
             age

        Exclusion Criteria:

          -  Hypersensitivity, allergy, or contraindications to fentanyl, propofol, or ketamine.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David M Smyth, MSN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shands Hospital at the University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 13, 2016</study_first_submitted>
  <study_first_submitted_qc>December 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2016</study_first_posted>
  <last_update_submitted>December 24, 2018</last_update_submitted>
  <last_update_submitted_qc>December 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Narcotics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>May 27, 2020</submitted>
    <returned>June 15, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

